健康
远程医疗
医学
心理干预
血压
数字健康
荟萃分析
随机对照试验
远程医疗
物理疗法
医疗保健
护理部
内科学
经济
经济增长
作者
Hao Jeun Yap,Jun Jie Lim,Doreen Su‐Yin Tan,Chin-Siang Ang
标识
DOI:10.1097/hjh.0000000000003793
摘要
Background: Hypertension, a risk factor for developing cardiovascular disease, is becoming increasingly prevalent worldwide. Digital health is now widely utilized for hypertension management, and numerous studies have assessed its effectiveness. Objective: The review aims to analyse the effectiveness of digital health (i.e., mobile health (mHealth), telehealth, and the combination of mHealth & telehealth) on hypertensive patients, concerning three key areas: clinical outcomes, medication adherence, and adherence to lifestyle changes, as compared to standard care. Methods: The review followed the PRISMA framework. Eight electronic databases were scanned for randomized control trials focusing on the effects of mHealth or telehealth on hypertensive patients, published between 2010 and 2023. All processes were conducted by the first two authors independently. A meta-analysis was conducted for quantitative data, while a narrative synthesis was conducted for qualitative data. Results: In total, 74 studies involving 92 686 participants were identified. The meta-analysis favoured the interventions, revealing a significant decrease in systolic blood pressure and diastolic blood pressure for mHealth, telehealth and mHealth & telehealth groups. Nevertheless, medication adherence showed improvement only in the mHealth group, while blood pressure control showed improvement in both mHealth and mHealth & telehealth groups, and BMI showed improvement only in the mHealth group. Evidence for adherence to physical activity and DASH diet/salt intake remained inconclusive. Conclusion: In general, mHealth and telehealth have demonstrated their merits in improving the clinical outcomes of hypertensive patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI